Peer Review History
| Original SubmissionOctober 21, 2024 |
|---|
|
PONE-D-24-42374Early detection of esophageal cancer: evaluating ai algorithms with multi-institutional narrorwband and white-light imaging dataPLOS ONE Dear Dr. Kim, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 18 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Hirenkumar Kantilal Mewada Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. Thank you for stating the following financial disclosure: [This work was supported by a grant from the Korean Gastrointestinal Endoscopy Research Foundation (2021 Investigation Grant), and by the Gachon University Gil Medical Center (Grant number: FRD2022-12), and by the Gachon University research fund of 2023(GCU-202308020001)]. Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical. Additional Editor Comments: One or more of the reviewers has recommended that you cite specific previously published works. Members of the editorial team have determined that the works referenced are not directly related to the submitted manuscript. As such, please note that it is not necessary or expected to cite the works requested by the reviewer. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this paper, the authors propose a method to detect tumors in esophageal endoscopy images using innovative artificial intelligence techniques for early diagnosis and detection of esophageal cancer. Esophageal cancer is one of the most common cancers worldwide, especially esophageal squamous cell carcinoma, which is often diagnosed at a late stage and has a poor prognosis. Therefore, the topic handled in this work is important. The proposed approach can be helpful for other researchers. However, the following revisions are required to improve the quality of the paper; 1) In the abstract section, some important numerical results should be added to inform the readers about the performance and effectiveness of the proposed method. 2) Grammatical mistakes should be corrected. 3) The loss and activation functions used in this work should be written. 4) The last section should be "Conclusion". In the discussion section, the advantages/superiority of the proposed approach should be explained. Also, limitations/drawbacks should be added. Possible extensions of this work and future works should be added. In future work, the effectiveness of the proposed approach can be investigated for lesion detection from dermoscopy images, which are colored images, and an effective AI-based method is needed in this field although there are recent advancements. Also, as another future work, the proposed method can be modified to achieve abdominal organ segmentation, such as the liver and kidneys, from grayscale medical images because noise and low contrasts make their segmentations difficult, and atlas or level set-based methods are not always effective. Therefore, the following statements should be added; "As a future work, the performance of the proposed method can be tested for the classification of dermatological diseases from dermoscopy images because detection of skin lesions is challenging and an AI-based effective method is still desired in this field despite some recent approaches [R1-R3]. Also, as another future work, the proposed method can be modified to achieve abdominal organ segmentation, such as the liver and kidneys, from grayscale medical images because noise and low contrasts make their segmentations difficult, and atlas or level set-based methods [R4-R9] are not always effective. R1: Automated Skin Cancer Detection: Where We Are and The Way to The Future, https://doi.org/10.1109/TSP52935.2021.9522605 R2: Convolutional neural network based desktop applications to classify dermatological diseases, https://doi.org/10.1109/IPAS50080.2020.9334956 R3: Comparative evaluations of cnn based networks for skin lesion classification, Int.Conf.onon Computer Graphics, Visualization, Computer Vision and Image Processing (CGVCVIP) R4: A comparative performance evaluation of various approaches for liver segmentation from SPIR images, https://doi.org/10.3906/elk-1304-36 R5: A neural network based kidney segmentation from MR images, https://doi.org/10.1109/ICMLA.2015.229 R6: A method for liver segmentation in perfusion MR images using probabilistic atlases and viscous reconstruction, https://doi.org/10.1007/s10044-017-0666-z R7: A comparative evaluation for liver segmentation from spir images and a novel level set method using signed pressure force function, Phd thesis, Izmir Institute of Technology R8: An automatic level set based liver segmentation from MRI data sets, https://doi.org/10.1109/IPTA.2012.6469551 R9: Automatic kidney segmentation using Gaussian mixture model on MRI sequences, https://doi.org/10.1007/978-3-642-21747-0_4 Reviewer #2: You have done a commendable work but I believe the comments below can improve the work; Comment #1: Check the typographical error in the last sentence before the conclusion of the introduction. You wrote "om" instead of "on." Then, go through the entire work to rectify typographical errors. Comment #2: The part of the introduction containing the literature is scanty and must be elaborated on. There is a lot of work on esophageal cancer using AI, and I think you need to reference or add more of this coupled with the evaluation metric values attained. Comment #3: It would like you to show the confusion matrices that you used to calculate TP, TN, FP, FN, precision, Sensitiviy etc. in the tables and in the text. Comment #4: If this dataset has been used by any AI algorithm before, a comparative analysis with the authors' results and the existing models' results will help readers and researchers appreciate your efforts. Comment #5: It would have been good if the Accuracy evaluation metric was also used to assess the models. Comment #6: You indicated you were proposing an AI algorithm, but I saw the use of existing models and did not see your novelty in this study. Therefore, I would like you to highlight your novelty. Comment #7: If possible, let's have a link to the dataset you used in this study. Reviewer #3: The paper presents commendable work. However, several aspects require further clarification and elaboration to improve the transparency and impact of the study. • Contributions 1. Can the authors provide a clear summary of the key contributions of their work? Highlighting the novelty and practical implications will help better understand the overall significance of the study. • Dataset 1. Annotation Process: How were the annotations verified? Were domain experts involved in the process? 2. Data Leakage: Patient-level leakage is a critical concern in medical imaging datasets. Please detail the measures taken to prevent such leakage. For instance, were all images from a single patient assigned exclusively to either the training, validation, or test sets? 3. Dataset Size: Given the relatively small size of the dataset, were data augmentation techniques employed to increase its size? If yes, please describe the augmentation strategies used. 4. Class Imbalance: How did the authors address class imbalance in the dataset? • Model Selection 1. What motivated the selection of YOLOv5 and RetinaNet for this study? Were alternative models considered? 2. Please provide details of any modifications made to the baseline architectures of YOLOv5 and RetinaNet. • Performance Evaluation 1. Comparison with State-of-the-Art: The results appear promising; however, the authors are encouraged to provide a direct comparison with state-of-the-art methods. While datasets may differ, comparisons with studies using esophageal datasets (e.g. leveraging WLI or NBI) would provide additional context. A summary table would be helpful for this purpose. 2. Confusion Matrix: To better visualize the model's performance, confusion matrices should be included, detailing metrics such as TP/FP/TN/FN. This will provide clearer insights into class-wise behavior. Addressing these points will enhance the clarity, transparency, and overall impact of the manuscript. Considering PLOS ONE’s specific guidelines on code sharing ‘https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code’ for submissions involving author-generated code, I would encourage the authors to share their code in a way that supports the findings in the manuscript. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-24-42374R1Early detection of esophageal cancer: evaluating ai algorithms with multi-institutional narrorwband and white-light imaging dataPLOS ONE Dear Dr. Kim, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Check comments received from the reviewer 2. Please submit your revised manuscript by Mar 28 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Hirenkumar Kantilal Mewada Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The proposed approach and the result will be helpful for many researchers. The paper has been carefully revised by the authors. After all revisions, the quality of the paper has been improved. Therefore, the revised version can be accepted for publication. Reviewer #2: Comment #1: I only saw the TP, TN, FP, and FN but not the confusion matrices that were used to calculate them. It would be better if those matrices were shown. Comment #2: It would have been good if there were extra novelties highlighted rather than only dataset and hyperparameter tuning. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Early detection of esophageal cancer: evaluating ai algorithms with multi-institutional narrorwband and white-light imaging data PONE-D-24-42374R2 Dear Dr. Kim, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hirenkumar Kantilal Mewada Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-42374R2 PLOS ONE Dear Dr. Kim, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Hirenkumar Kantilal Mewada Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .